Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 308

1.

Technical success rates and reliability of spin-echo echo-planar imaging (SE-EPI) MR elastography in patients with chronic liver disease or liver cirrhosis.

Choi SL, Lee ES, Ko A, Park HJ, Park SB, Choi BI, Cho YY, Kannengiesser S.

Eur Radiol. 2019 Nov 14. doi: 10.1007/s00330-019-06496-y. [Epub ahead of print]

PMID:
31728687
2.

Controlling complexation/decomplexation and sizes of polymer-based electrostatic pDNA polyplexes is one of the key factors in effective transfection.

Kim K, Hwang HS, Shim MS, Cho YY, Lee JY, Lee HS, Kang HC.

Colloids Surf B Biointerfaces. 2019 Dec 1;184:110497. doi: 10.1016/j.colsurfb.2019.110497. Epub 2019 Sep 9.

PMID:
31536938
3.

Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells.

Lee HE, Lee JY, Yang G, Kang HC, Cho YY, Lee HS, Lee JY.

Sci Rep. 2019 Aug 22;9(1):12277. doi: 10.1038/s41598-019-48794-x.

4.

In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters.

Kim S, Choi WG, Kwon M, Lee S, Cho YY, Lee JY, Kang HC, Song IS, Lee HS.

Molecules. 2019 Aug 19;24(16). pii: E3000. doi: 10.3390/molecules24163000.

5.

Publisher Correction: Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality.

Lee YB, Nam JY, Lee JH, Chang Y, Cho H, Cho YY, Cho EJ, Yu SJ, Kim HY, Lee DH, Lee JM, Hwang SG, Kim YJ, Yoon JH.

Sci Rep. 2019 Aug 16;9(1):12146. doi: 10.1038/s41598-019-48367-y.

6.

Identification of Catalposide Metabolites in Human Liver and Intestinal Preparations and Characterization of the Relevant Sulfotransferase, UDP-glucuronosyltransferase, and Carboxylesterase Enzymes.

Hwang DK, Kim JH, Shin Y, Choi WG, Kim S, Cho YY, Lee JY, Kang HC, Lee HS.

Pharmaceutics. 2019 Jul 22;11(7). pii: E355. doi: 10.3390/pharmaceutics11070355.

7.

Synthesis of Flavanones via Palladium(II)-Catalyzed One-Pot β-Arylation of Chromanones with Arylboronic Acids.

Yoo HS, Son SH, Cho YY, Lee SJ, Jang HJ, Kim YM, Kim DH, Kim NY, Park BY, Lee YS, Kim NJ.

J Org Chem. 2019 Aug 16;84(16):10012-10023. doi: 10.1021/acs.joc.9b01162. Epub 2019 Jul 26.

PMID:
31322349
8.

Are patients with mild to moderate renal impairment on metformin or other oral anti-hyperglycaemic agents at increased risk of contrast-induced nephropathy and metabolic acidosis after radiocontrast exposure?

Jung J, Cho YY, Jung JH, Kim KY, Kim HS, Baek JH, Hahm JR, Cho HS, Kim SK.

Clin Radiol. 2019 Aug;74(8):651.e1-651.e6. doi: 10.1016/j.crad.2019.05.011. Epub 2019 Jun 12.

PMID:
31202566
9.

Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis.

Lee HE, Yang G, Park YB, Kang HC, Cho YY, Lee HS, Lee JY.

Molecules. 2019 Jun 6;24(11). pii: E2138. doi: 10.3390/molecules24112138.

10.

O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production.

Kwon OH, Cho YY, Kim TW, Chung S.

J Alzheimers Dis. 2019;69(4):1195-1211. doi: 10.3233/JAD-190060.

PMID:
31156159
11.

NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3β-NDRG2-PP2A Complex Formation.

Park S, Han HT, Oh SS, Kim DH, Jeong JW, Lee KW, Kim M, Lim JS, Cho YY, Hwangbo C, Yoo J, Kim KD.

Cells. 2019 May 22;8(5). pii: E495. doi: 10.3390/cells8050495.

12.

Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic Syndrome.

Park S, Baek DW, Sohn SK, Ahn JS, Kim HJ, Shin HJ, Chung JS, Lee SM, Lee WS, Lim SN, Lee YJ, Choi Y, Lee HS, Cho YY, Lee GW, Moon JH.

Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e367-e373. doi: 10.1016/j.clml.2019.03.016. Epub 2019 Apr 11.

PMID:
31060990
13.

Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B.

Cho YY, Chang Y, Nam JY, Cho H, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ.

Gut Liver. 2019 Aug 15. doi: 10.5009/gnl18474. [Epub ahead of print]

14.

Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B.

Cho H, Chang Y, Lee JH, Cho YY, Nam JY, Lee YB, Lee DH, Cho EJ, Yu SJ, Kim YJ, Lee JM, Yoon JH.

J Clin Gastroenterol. 2019 Apr 26. doi: 10.1097/MCG.0000000000001217. [Epub ahead of print]

PMID:
31033805
15.

RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.

Yoo SM, Lee CJ, An HJ, Lee JY, Lee HS, Kang HC, Cho SJ, Kim SM, Park J, Kim DJ, Cho YY.

Int J Mol Sci. 2019 Apr 23;20(8). pii: E1994. doi: 10.3390/ijms20081994.

16.

The Differential Effect of Excess Aldosterone on Skeletal Muscle Mass by Sex.

Kwak MK, Lee SE, Cho YY, Suh S, Kim BJ, Song KH, Koh JM, Kim JH, Lee SH.

Front Endocrinol (Lausanne). 2019 Mar 29;10:195. doi: 10.3389/fendo.2019.00195. eCollection 2019.

17.

Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.

Yoo SM, Lee CJ, Kang HC, Lee HS, Lee JY, Kim KD, Kim DJ, An HJ, Cho YY.

Mol Carcinog. 2019 Jul;58(7):1221-1233. doi: 10.1002/mc.23005. Epub 2019 Mar 18.

PMID:
30887599
18.

Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.

Yoo JJ, Yu SJ, Na J, Kim K, Cho YY, Lee YB, Cho EJ, Lee JH, Kim YJ, Youn H, Yoon JH.

Int J Mol Sci. 2019 Mar 14;20(6). pii: E1292. doi: 10.3390/ijms20061292.

19.

In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-N-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography⁻Mass Spectrometry.

Kim JH, Kim S, Lee J, In S, Cho YY, Kang HC, Lee JY, Lee HS.

Molecules. 2019 Feb 25;24(4). pii: E818. doi: 10.3390/molecules24040818.

20.

Carbonic anhydrase-IX inhibition enhances the efficacy of hexokinase II inhibitor for hepatocellular carcinoma in a murine model.

Cho EJ, Yu SJ, Kim K, Cho H, Cho YY, Lee YB, Lee JH, Kim YJ, Youn H, Yoon JH.

J Bioenerg Biomembr. 2019 Apr;51(2):121-129. doi: 10.1007/s10863-019-09788-6. Epub 2019 Feb 12.

PMID:
30746618
21.

The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.

Ahn SH, Kim JH, Cho YY, Suh S, Kim BJ, Hong S, Lee SH, Koh JM, Song KH.

Osteoporos Int. 2019 May;30(5):1059-1069. doi: 10.1007/s00198-019-04871-5. Epub 2019 Feb 4.

PMID:
30719548
22.

Reply to letter to editor regarding: "A clinical prediction model to estimate the metastatic potential of Pheochromocytoma/paraganglioma: ASES score".

Cho YY, Kwak MK, Lee SE, Kim JH, Lee SH.

Surgery. 2019 Apr;165(4):853-858. doi: 10.1016/j.surg.2018.11.016. Epub 2019 Jan 24. No abstract available.

PMID:
30686514
23.

Elevated cellular cholesterol in Familial Alzheimer's presenilin 1 mutation is associated with lipid raft localization of β-amyloid precursor protein.

Cho YY, Kwon OH, Park MK, Kim TW, Chung S.

PLoS One. 2019 Jan 25;14(1):e0210535. doi: 10.1371/journal.pone.0210535. eCollection 2019.

24.

Hepatitis B virus X protein induces size-selective membrane permeabilization through interaction with cardiolipin.

You DG, Cho YY, Lee HR, Lee JH, Yu SJ, Yoon JH, Yoo YD, Kim YJ, Lee GY.

Biochim Biophys Acta Biomembr. 2019 Apr 1;1861(4):729-737. doi: 10.1016/j.bbamem.2019.01.006. Epub 2019 Jan 16.

PMID:
30658058
25.

Analysis of significant protein abundance from multiple reaction-monitoring data.

Jun J, Gim J, Kim Y, Kim H, Yu SJ, Yeo I, Park J, Yoo JJ, Cho YY, Lee DH, Cho EJ, Lee JH, Kim YJ, Lee S, Yoon JH, Kim Y, Park T.

BMC Syst Biol. 2018 Dec 31;12(Suppl 9):123. doi: 10.1186/s12918-018-0656-9.

26.

Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.

Battogtokh G, Choi YS, Kang DS, Park SJ, Shim MS, Huh KM, Cho YY, Lee JY, Lee HS, Kang HC.

Acta Pharm Sin B. 2018 Oct;8(6):862-880. doi: 10.1016/j.apsb.2018.05.006. Epub 2018 May 18. Review.

27.

Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin.

Cho YY, Kim SK, Jung JH, Hahm JR, Kim TH, Chung JH, Kim SW.

Endocrine. 2019 May;64(2):293-298. doi: 10.1007/s12020-018-1807-x. Epub 2018 Nov 23.

PMID:
30471053
28.

The Model to Estimate Survival in Ambulatory Hepatocellular Carcinoma Patients Aids in the Decision for TACE Retreatment.

Cho YY, Yu SJ, Yoo JJ, Lee M, Lee DH, Cho Y, Yoon KW, Cho EJ, Lee JH, Kim YJ, Yoon JH.

J Clin Gastroenterol. 2018 Nov 14. doi: 10.1097/MCG.0000000000001148. [Epub ahead of print]

PMID:
30439763
29.

Justicidin A Reduces β-Amyloid via Inhibiting Endocytosis of β-Amyloid Precursor Protein.

Chun YS, Kwon OH, Oh HG, Cho YY, Yang HO, Chung S.

Biomol Ther (Seoul). 2019 May 1;27(3):276-282. doi: 10.4062/biomolther.2018.112.

30.

Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy.

Lee IH, Kang BW, Kim JG, Bae WK, Ki MS, Park I, Jo JC, Kim JY, Koh SA, Lee KH, Cho YY, Ryoo HM, Kwak SG, Lee JL, Lee SA.

Korean J Intern Med. 2018 Oct 12. doi: 10.3904/kjim.2018.064. [Epub ahead of print]

31.

Licochalcone A attenuates acne symptoms mediated by suppression of NLRP3 inflammasome.

Yang G, Lee HE, Yeon SH, Kang HC, Cho YY, Lee HS, Zouboulis CC, Han SH, Lee JH, Lee JY.

Phytother Res. 2018 Dec;32(12):2551-2559. doi: 10.1002/ptr.6195. Epub 2018 Oct 3.

PMID:
30281174
32.

Change of skeletal muscle mass in patients with pheochromocytoma.

Lee SH, Kwak MK, Ahn SH, Kim H, Cho YY, Suh S, Song KH, Koh JM, Kim JH, Kim BJ.

J Bone Miner Metab. 2019 Jul;37(4):694-702. doi: 10.1007/s00774-018-0959-3. Epub 2018 Sep 20.

PMID:
30238430
33.

Magnolin targeting of ERK1/2 inhibits cell proliferation and colony growth by induction of cellular senescence in ovarian cancer cells.

Song JH, Lee CJ, An HJ, Yoo SM, Kang HC, Lee JY, Kim KD, Kim DJ, Lee HS, Cho YY.

Mol Carcinog. 2019 Jan;58(1):88-101. doi: 10.1002/mc.22909. Epub 2018 Sep 21.

34.

Treatment variation related to comorbidity and complications in type 2 diabetes: A real world analysis.

Cho YY, Cho SI.

Medicine (Baltimore). 2018 Sep;97(37):e12435. doi: 10.1097/MD.0000000000012435.

35.

Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality.

Lee YB, Nam JY, Lee JH, Chang Y, Cho H, Cho YY, Cho EJ, Yu SJ, Kim HY, Lee DH, Lee JM, Hwang SG, Kim YJ, Yoon JH.

Sci Rep. 2018 Sep 12;8(1):13651. doi: 10.1038/s41598-018-31839-y. Erratum in: Sci Rep. 2019 Aug 16;9(1):12146.

36.

Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling.

Kim M, Morales LD, Jang IS, Cho YY, Kim DJ.

Int J Mol Sci. 2018 Sep 11;19(9). pii: E2708. doi: 10.3390/ijms19092708. Review.

37.

Antiobesity Effects of Short-Chain Chitosan in Diet-Induced Obese Mice.

Do AR, Cho SJ, Cho YY, Kwon EY, Choi JY, Lee JH, Han Y, Kim YS, Piao Z, Shin YC, Choi MS.

J Med Food. 2018 Sep;21(9):927-934. doi: 10.1089/jmf.2017.4115. Epub 2018 Sep 5.

PMID:
30183503
38.

Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment.

Battogtokh G, Cho YY, Lee JY, Lee HS, Kang HC.

Front Pharmacol. 2018 Aug 17;9:922. doi: 10.3389/fphar.2018.00922. eCollection 2018. Review.

39.

Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma.

Park SY, Cho YY, Kim HI, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Kim K, Kim SW, Chung JH, Kim TH.

J Clin Endocrinol Metab. 2018 Dec 1;103(12):4609-4616. doi: 10.1210/jc.2018-01386.

PMID:
30137493
40.

Thyroid function tests in patients at the emergency department compared to a prior healthy setting.

Kim RB, Kim M, Cho YY, Kim SK, Jung JH, Jung J, Kim CY, Kang D, Hahm JR.

PLoS One. 2018 Aug 20;13(8):e0202422. doi: 10.1371/journal.pone.0202422. eCollection 2018.

41.

Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK.

Lee S, Cho YY, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ.

Int J Mol Med. 2018 Nov;42(5):2551-2559. doi: 10.3892/ijmm.2018.3807. Epub 2018 Aug 3.

42.

Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts.

Baek DW, Lee YJ, Kim H, Ahn SY, Ahn JS, Shin HJ, Lee WS, Lee SM, Song IC, Lee HS, Park SW, Choi Y, Cho YY, Bae SH, Kim HJ, Sohn SK, Moon JH.

Ann Hematol. 2018 Dec;97(12):2309-2317. doi: 10.1007/s00277-018-3458-7. Epub 2018 Aug 2.

PMID:
30073392
43.

Prognosis of Differentiated Thyroid Carcinoma with Initial Distant Metastasis: A Multicenter Study in Korea.

Kim H, Kim HI, Kim SW, Jung J, Jeon MJ, Kim WG, Kim TY, Kim HK, Kang HC, Han JM, Cho YY, Kim TH, Chung JH.

Endocrinol Metab (Seoul). 2018 Jun;33(2):287-295. doi: 10.3803/EnM.2018.33.2.287.

44.

A clinical prediction model to estimate the metastatic potential of pheochromocytoma/paraganglioma: ASES score.

Cho YY, Kwak MK, Lee SE, Ahn SH, Kim H, Suh S, Kim BJ, Song KH, Koh JM, Kim JH, Lee SH.

Surgery. 2018 Sep;164(3):511-517. doi: 10.1016/j.surg.2018.05.001. Epub 2018 Jun 19.

PMID:
29929757
45.

Targeting PRPK and TOPK for skin cancer prevention and therapy.

Roh E, Lee MH, Zykova TA, Zhu F, Nadas J, Kim HG, Bae KB, Li Y, Cho YY, Curiel-Lewandrowski C, Einspahr J, Dickinson SE, Bode AM, Dong Z.

Oncogene. 2018 Oct;37(42):5633-5647. doi: 10.1038/s41388-018-0350-9. Epub 2018 Jun 14.

46.

Simultaneous quantification of 18 saturated and unsaturated fatty acids and 7 sterols as their tert-butyldimethylsilyl derivatives in human saliva using gas chromatography-tandem mass spectrometry.

Moon JY, Kong TY, Jang HJ, Kang HC, Cho YY, Lee JY, Lee HS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:114-121. doi: 10.1016/j.jchromb.2018.06.003. Epub 2018 Jun 2.

PMID:
29886289
47.

Effects of the Physicochemical, Colloidal, and Biological Characteristics of Different Polymer Structures between α-Poly(l-lysine) and ε-Poly(l-lysine) on Polymeric Gene Delivery.

Kim K, Ryu K, Choi YS, Cho YY, Lee JY, Lee HS, Chang Kang H.

Biomacromolecules. 2018 Jul 9;19(7):2483-2495. doi: 10.1021/acs.biomac.8b00097. Epub 2018 Jun 13.

PMID:
29864279
48.

Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea.

Cho YY, Kang MJ, Kim SK, Jung JH, Hahm JR, Kim TH, Nam JY, Lee BW, Lee YH, Chung JH, Song SO, Kim SW.

Thyroid. 2018 Jul;28(7):864-870. doi: 10.1089/thy.2017.0550. Epub 2018 Jun 29.

PMID:
29808777
49.

Characteristics of Adrenal Incidentalomas in a Large, Prospective Computed Tomography-Based Multicenter Study: The COAR Study in Korea.

Ahn SH, Kim JH, Baek SH, Kim H, Cho YY, Suh S, Kim BJ, Hong S, Koh JM, Lee SH, Song KH.

Yonsei Med J. 2018 Jun;59(4):501-510. doi: 10.3349/ymj.2018.59.4.501.

50.

Comparison of overall survival between antiviral-induced viral suppression and inactive phase chronic hepatitis B patients.

Cho YY, Lee JH, Chang Y, Nam JY, Cho H, Lee DH, Cho EJ, Lee DH, Yu SJ, Lee JM, Kim YJ, Yoon JH.

J Viral Hepat. 2018 Oct;25(10):1161-1171. doi: 10.1111/jvh.12927. Epub 2018 May 24.

PMID:
29741286

Supplemental Content

Support Center